SCHEMBL9000575

SCHEMBL9000575

CSc1cc(C)nc(SC)c1NC(=O)C(SCc1ccccc1)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ SOAT1 P35610 6/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ ALDH1A1 P00352 5/20 0.37
▸ PKM P14618 1/20 0.37
▸ KMT2A Q03164 2/20 0.35
▸ VCP P55072 1/20 0.35
▸ SIRT2 Q8IXJ6 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ CYP1A2 P05177 2/20 0.34
▸ CYP3A4 P08684 2/20 0.34
▸ CYP2C9 P11712 2/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9000651 0.94 SOAT1 (0.41) SOAT1NPSR1ALDH1A1SMN1; SMN2CYP1A2
SCHEMBL9000713 0.94 EPHX1 (0.43) SOAT1NPSR1ALDH1A1PKMKMT2A
SCHEMBL9000506 0.92 SOAT1 (0.39) SOAT1NPSR1ALDH1A1SMN1; SMN2
SCHEMBL9000898 0.92 EPHX1 (0.46) SOAT1ALDH1A1KMT2ACYP3A4KDM4E
SCHEMBL9000520 0.92 GSK3B (0.37) SOAT1ALDH1A1
SCHEMBL9000445 0.91 POLB (0.43) SOAT1ALDH1A1KMT2AMEN1MAPT
SCHEMBL9000753 0.91 SOAT1 (0.39) SOAT1NPSR1ALDH1A1KMT2ASMN1; SMN2
SCHEMBL9000604 0.90 EPHX1 (0.47) SOAT1ALDH1A1KMT2ACYP1A2CYP3A4
SCHEMBL9000398 0.90 EPHX1 (0.47) SOAT1PKMKMT2ASMN1; SMN2KDM4E
SCHEMBL9000588 0.90 EPHX1 (0.38) SOAT1ALDH1A1CYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5583147-A INHIBITORS OF ACYL-COENZYME A: CHOLESTEROL O-TRANSFERASE; ANTIHYPERCHOLESTEROLEMIC AND/OR ANTIATHEROSCLEROTIC AGENTS THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1996-12-10 — — US disclosed
Send feedback